Butaxamine

Butaxamine has been studied in 1 paper since 2022: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Dec 13, 2022: “Beta 2 Adrenergic Receptor Selective Antagonist Enhances Mechanically Stimulated Bone Anabolism in Aged Mice”.

Intervention

1 paper studies it2 findingsUpdated

PubChem

See all 1 papers on butaxamine

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: National Institute of Arthritis and Musculoskeletal and Skin Diseases and 1 more
  • Animals1

What did studies of butaxamine find?

2

Studies of butaxamine measured 2 outcomes: osteoblasts and periosteal bone formation.

Osteoblasts

no changein mice1

1 study
  1. Butaxamine showed no clear effect on osteoblasts in mice (contralateral unloaded tibia).

    “Butax treatment did not alter osteoblast activity of contralateral tibias.”

    Animalscontralateral unloaded tibiatibia

    Beta 2 Adrenergic Receptor Selective Antagonist Enhances Mechanically Stimulated Bone Anabolism in Aged Mice

    JBMR plus

More on Osteoblasts

Periosteal bone formation

upin mice1

1 study
  1. Butaxamine increases periosteal bone formation in mice (combined with tibial cantilever bending loading).

    “when loading was combined with Butax pretreatment, the anabolic response was significantly elevated compared with loading preceded by saline injection”

    Animalscombined with tibial cantilever bending loadingtibia

    Beta 2 Adrenergic Receptor Selective Antagonist Enhances Mechanically Stimulated Bone Anabolism in Aged Mice

    JBMR plus

More on Periosteal bone formation

Latest